Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi. [electronic resource]

By:

Luebke, A L

Contributor(s):

Wilary, D M
Mahoney, D W
Hung, J C

Producer: 20010315Description: 259-63 p. digitalISSN:

0091-4916

Subject(s):

Acetates
Chromatography, Paper
Chromatography, Thin Layer
Quality Control
Radiopharmaceuticals -- standards
Technetium Tc 99m Sestamibi -- standards

In: Journal of nuclear medicine technology vol. 28

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Evaluation Study; Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
by Tonato, M
2 Combination therapy with gemcitabine in non-small cell lung cancer.
by Mosconi, A M
3 Safety profile of gemcitabine.
by Tonato, M
4 5-Fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation.
by Colozza, M
5 Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
by Colozza, M
6 Gemcitabine in advanced pancreatic cancer: a phase II trial.
by Crinò, L
7 A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
by Crinò, L
8 Regional node failure in patients with four or more positive lymph nodes submitted to conservative surgery followed by radiotherapy to the breast.
by Aristei, C
9 Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin.
by Colozza, M
10 Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results.
by Colozza, M
11 Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer.
by Colozza, M
12 Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
by Cocconi, G
13 Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients.
by Gori, S
14 Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.
by Crinò, L
15 Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.
by Gori, S
16 The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
by Mangili, G
17 Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial.
by Crinò, L
18 A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
by Rinaldi, M
19 Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.
by Ludovini, V
20 Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study.
by Colozza, M

Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi.

APA

Luebke A. L., Wilary D. M., Mahoney D. W. & Hung J. C. (20010315). Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi. : Journal of nuclear medicine technology.

Chicago

Luebke A L, Wilary D M, Mahoney D W and Hung J C. 20010315. Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi. : Journal of nuclear medicine technology.

Harvard

Luebke A. L., Wilary D. M., Mahoney D. W. and Hung J. C. (20010315). Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi. : Journal of nuclear medicine technology.

MLA

Luebke A L, Wilary D M, Mahoney D W and Hung J C. Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi. : Journal of nuclear medicine technology. 20010315.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC